University of California brings expertise to new multi-institutional study of California’s global health dividend
A new study of the benefits of global health investment for the Golden State tapped multiple UCLA scholars, including UCLA Fielding's Dr. Anne Rimoin.
A new effort to research how California benefits from American investment in global health is bringing together scholars from universities from across the state, including UCLA, USC, and UC San Francisco.
“We can't just be looking within California when we are trying to think about what emerging threats we have,” said Dr. Anne Rimoin, associate dean for global health at the UCLA Fielding School of Public Health, who spoke at the effort’s California roll-out Nov. 12 in Los Angeles. “I spent the last quarter of a century working in Central Africa, in the Democratic Republic of Congo, and one of the most important lessons that I've learned is that relationships and trust and scientific capacity cannot be built right in the middle of a crisis. That's not the time to get started.”
The effort, the California Global Health Leadership Initiative, published a 118-page report this month – “California’s Global Health Dividend: The Case for State Leadership” – that covers a wide range of global health issues and the benefits to the state of California.
“With this study we wanted to ask: does US and state investment in global health actually benefit Californians? Is there a tangible dividend for people in the state?,” said Chris Collins, president and CEO of the Washington, D.C.-based Friends of the Global Fight Against AIDS, Tuberculosis, and Malaria, a partner in the effort. “We found unequivocally the answer is yes. We documented multiple benefits ranging from economic growth to public safety, to research and industry innovation, and to the state’s relationships and place in the world.”
In the report, researchers found that U.S. global health investment has a far-reaching impact on California’s health and safety, economy, industry and innovation, and global impact and standing. Among the key findings:
- Every $1 in federal global health spending in California generates an estimated $1.40 to $2.15 in economic activity, contributing to more than $46 billion over the study period.
- Global health investments support California’s research institutions and industries, creating demand for new health technologies and products.
- Global health partnerships strengthen California’s ability to detect and respond to emerging health threats, helping protect communities at home and abroad.
“This is an alliance, a powerful alliance to mobilize evidence-informed leadership for global health, and in this case, by evidence, we're talking about evidence of the mutual benefit of global health to the constituents of all countries,” said Prof. Jonathan Cohen, director of policy engagement at the USC Institute on Inequalities in Global Health and the study’s editor. “In calling for more global health leadership, we are making the point that global health is a two-way street, that cooperating to address health-related threats and opportunities is in everyone's best interests.”
Led by the USC Institute on Inequalities in Global Health as part of the California Global Health Leadership Initiative, the study highlights the deep connections between global health and the health, economic and scientific infrastructure of U.S. states. This includes experience and lessons learned from past health crises, University of California experts said.
“This report is a great blueprint for what we need to do moving forward,” said Dr. Thomas J. Coates, distinguished research professor at the UCLA David Geffen School of Medicine and director emeritus of the University of California Global Health Institute. “I was diagnosed with HIV in 1985. That was 41 years ago. The only reason I'm here today It's because of research. It's not the only reason, but it's a major reason and a lot of that research was conducted by people in California … (and) that also translated worldwide.”
Other participants from the University of California include Prof. Lara Stemple, assistant dean for graduate studies and international programs at the UCLA School of Law, who also serves with the UC Global Health Institute, as does Dr. Madhavi Dandu, along with UCSF's Dr. Payam Nahid, Andrea DeLuca, and Allison Tatarsky Berman. Other contributing authors or partners came from Charles R. Drew University in Los Angeles, Stanford University, the Alliance for Innovation in Global Health, Friends of the Global Fight Against AIDS, Tuberculosis and Malaria and the Global Health Security Network. The project was supported by Coefficient Giving.
Along with events in Washington, D.C on Nov. 10 and in Los Angeles Nov. 12, the report will be discussed at an event from 3-5 pm Wednesday, Nov. 18 at the University of California, San Francisco. In addition, the Association of Schools & Programs of Public Health (ASPPH) released a report Nov. 11 on similar themes – “Advancing Global Health in Academic Public Health” - whose contributors include Dr. Kamiar Alaei from California State University, Long Beach.
“Global health is an essential part of how we protect our communities, training our workforce, driving innovation, and preparing for the future,” said Rimoin, who also serves as a professor in the Department of Epidemiology, holder of the Gordon–Levin Endowed Chair in Infectious Diseases and Public Health, and director of the UCLA Fielding School’s Center for Global Health Security. “The key here, as academics, (is) thinking about - concretely - how are we moving together into the future, and how do we make these partnerships really global reciprocal partnerships. I think that's what California is uniquely poised to do, with all the resources that we have.”